Qi et al
Crit Care Med 34:15891596 Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, de Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving Sepsis campaign: international guidelines for management of sepsis and septic shock: 2016
Casadevall says the reason his team's findings differ so much from previous retraction studies is that his team independently verified why each paper had been retracted
The consensus among practitioners indicates that Epithalon peptide demonstrates strong safety credentials when administered according to established protocols
Alpha lipoic acid, which also has robust antioxidant activity , here may enhance these benefits when used in combination
Researchers choose Biopeptides due to consistent product quality, high purity standards, clear documentation, and verified CAS identification